FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
- 1 April 2010
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 28 (16), 2801-2805
- https://doi.org/10.1016/j.vaccine.2009.11.025
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream productionBiotechnology Advances, 2009
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialVaccine, 2008
- Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult SubjectsThe Journal of Infectious Diseases, 2008
- Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trialJournal of General Virology, 2006
- In Vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in miceArchives of Pharmacal Research, 2003
- The Assessment of Local Tolerance, Acute Toxicity, and DNA Biodistribution Following Particle-Mediated Delivery of a DNA Vaccine to MinipigsToxicologic Pathology, 2002
- Do DNA Vaccines Induce Autoimmune Disease?Human Gene Therapy, 1997
- Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cellsImmunology, 1996
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990